Autolus Therapeutics Operating Expenses Growth & History (AUTL)
Autolus Therapeutics's operating expenses was $249.6M for fiscal 2025.
View full Autolus Therapeutics company overviewAutolus Therapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $249.6M | $9.4M | +3.92% |
| 2024 | 2024-12-31 | $240.2M | $58.8M | +32.39% |
| 2023 | 2023-12-31 | $181.4M | $32.3M | +21.67% |
| 2022 | 2022-12-31 | $149.1M | — | — |
| 2018 | 2018-09-30 | $57.5M | $34.1M | +145.68% |
| 2017 · Sep 30 | 2017-09-30 | $23.4M | $9.0M | +62.90% |
| 2016 | 2016-09-30 | $14.4M | — | — |
Autolus Therapeutics quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $69.1M | $11.4M | +19.70% |
| Q1 2026 | 2026-03-31 | $61.2M | $4.9M | +8.69% |
| Q4 2025 | 2025-12-31 | $71.4M | $6.9M | +10.73% |
| Q3 2025 | 2025-09-30 | $64.2M | −$3.7M | −5.46% |
| Q2 2025 | 2025-06-30 | $57.7M | −$1.2M | −2.09% |
| Q1 2025 | 2025-03-31 | $56.3M | $7.4M | +15.20% |
| Q4 2024 | 2024-12-31 | $64.5M | — | — |
| Q3 2024 | 2024-09-30 | $67.9M | — | — |
| Q2 2024 | 2024-06-30 | $58.9M | — | — |
| Q1 2024 | 2024-03-31 | $48.8M | — | — |
| Q3 2019 · Sep 30 | 2019-09-30 | $35.6M | $18.6M | +108.76% |
| Q3 2019 · Jun 30 | 2019-06-30 | $37.2M | $20.7M | +125.17% |
| Q1 2019 | 2018-12-31 | $25.0M | $16.6M | +197.14% |
| Q4 2018 | 2018-09-30 | $17.1M | — | — |
| Q2 2018 | 2018-06-30 | $16.5M | — | — |
| Q4 2017 | 2017-12-31 | $8.4M | — | — |
Autolus Therapeutics operating expenses trends
Between the periods ended 2016-09-30 and 2025-12-31, Autolus Therapeutics's operating expenses increased from $14.4M to $249.6M, a change of $235.2M. The latest reported quarter, Q2 2026, shows $69.1M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Autolus Therapeutics source filings ↗